References
- Rosenberg JB, Hutcheson KA. Pediatric sickle cell retinopathy: correlation with clinical factors. J AAPOS. 2011;15(1):49–53. doi:10.1016/j.jaapos.2010.11.014
- Pauling, L, Itano, HA, Singer, SJ, Wells, IC. Sickle cell anemia, a molecular disease. Science. 1949;109(2835):443. doi:10.1126/science.109.2833.386-a
- Elagouz M, Jyothi S, Gupta B, Sivaprasad S. Sickle cell disease and the eye: old and new concepts. Surv Ophthalmol. 2010;55:359–377. doi:10.1016/j.survophthal.2009.11.004
- Wang M, Hussnain SA, Chen RWS. The role of retinal imaging in sickle cell retinopathy: a review. Int Ophthalmol Clin. 2019;59(1):71–82. doi:10.1097/IIO.0000000000000255
- Hoang QV, Chau FY, Shahidi M, Lim JI. Central macular splaying and outer retinal thinning in asymptomatic sickle cell patients by spectral-domain optical coherence tomography. Am J Ophthalmol. 2011;151(6):990–994 e991. doi:10.1016/j.ajo.2010.12.010
- Brasileiro F, Martins TT, Campos SB, et al. Macular and peripapillary spectral domain optical coherence tomography changes in sickle cell retinopathy. Retina. 2015;35(2):257–263. doi:10.1097/IAE.0000000000000309
- Chow CC, Genead MA, Anastasakis A, Chau FY, Fishman GA, Lim JI. Structural and functional correlation in sickle cell retinopathy using spectral-domain optical coherence tomography and scanning laser ophthalmoscope microperimetry. Am J Ophthalmol. 2011;152(4):704–711 e702. doi:10.1016/j.ajo.2011.03.035
- Mathew R, Bafiq R, Ramu J, et al. Spectral domain optical coherence tomography in patients with sickle cell disease. Br J Ophthalmol. 2015;99(7):967–972. doi:10.1136/bjophthalmol-2014-305532
- Ilginis T, Keane PA, Tufail A. Paracentral acute middle maculopathy in sickle cell disease. JAMA Ophthalmol. 2015;133(5):614–616. doi:10.1001/jamaophthalmol.2014.6098
- Hussnain SA, Coady PA, Stoessel KM. Paracentral acute middle maculopathy: precursor to macular thinning in sickle cell retinopathy. BMJ Case Rep. 2017;2017:1–2.
- Lim JI, Cao D. Analysis of retinal thinning using spectral-domain optical coherence tomography imaging of sickle cell retinopathy eyes compared to age- and race-matched control eyes. Am J Ophthalmol. 2018;192:229–238. doi:10.1016/j.ajo.2018.03.013
- Dell’Arti L, Barteselli G, Riva L, et al. Sickle cell maculopathy: identification of systemic risk factors, and microstructural analysis of individual retinal layers of the macula. PLoS One. 2018;13(3):e0193582. doi:10.1371/journal.pone.0193582
- Fox PD, Dunn DT, Morris JS, Serjeant GR. Risk factors for proliferative sickle retinopathy. Br J Ophthalmol. 1990;74(3):172–176.
- Hayes RJ, Condon PI, Serjeant GR. Haematological factors associated with proliferative retinopathy in homozygous sickle cell disease. Br J Ophthalmol. 1981;65(1):29–35.